Sie sind auf Seite 1von 2

Media Release

3 July 2014



BUSINESS UPDATE PRELIMINARY INDICATIVE 30 JUNE 2014 GUIDANCE


Preliminary revenues for 30 June 2014 at $30 million, approximately 10% higher than FY2013
Preliminary results indicate a return to profitability for year to 30 June 2014
Cloud-based sleep diagnostic and monitoring platform (eHealth) potential business incremental
to the existing business

Compumedics Limited (ASX: CMP) is pleased to announce, for the year ended 30
th
June 2014, preliminary
results indicate that the Company will return to profitability having shipped and invoiced approximately
$30 million in sales. Final results will be subject to audit commencing later this month, with the Appendix
4E to be released to the ASX later in August.

In delivering this result the Company has ended 30
th
June 2014 with sales orders on hand of
approximately $5.6 million, reflecting a strong run of new sales orders into the business through to the
end of the financial year.

In addition, the results reflect the ongoing positive outcomes from the Companys continuing process of
transforming and relocating key manufacturing activities to lower cost countries. Together with the lower
Australian dollar compared to 12 months ago, these activities will continue to impact positively on the
business moving forward.

The announcement to the ASX yesterday (2
nd
July 2014), regarding the cloud-based sleep diagnostic and
monitoring platform (eHealth) contracts, reflects incremental and new business to the Company. The
potential revenue and income stream from these contracts will be in addition to the Companys existing
business on which guidance has been given today. The Company sees this opportunity as highly
complementary to its existing business.



















About Compumedics Limited
Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and
commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring
applications. The Company owns US based Neuroscan and Germany basedDWL Elektronishe GmbH. In
conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas;
Australia and Asia Pacific; and Europe and the Middle East.
Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company
successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in
Melbourne. Following this early success, Compumedics focused on the development of products that sold into
the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian
Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades
including Australias exporter of the year and has been recognised as a Top 100 Innovatorby the both German
and Australian Governments.

For more information please visit: www.compumedics.com

For further information please contact:




For investor relations and media enquiries please contact:
Dr David Burton, Executive Chairman, CEO
Compumedics Limited
T: + 61 3 8420 7300, F: +61 3 8420 7399

Mr David Lawson, Executive Director, CFO
Compumedics Limited
T: + 61 3 8420 7300, F: +61 3 8420 7399
Rod North, Managing Director,
Bourse Communications Pty Ltd
T: (03) 9510 8309, M: 0408 670 706
E: rod@boursecommunications.com.au

Das könnte Ihnen auch gefallen